Suicide, depression, and antidepressants

British Medical Journal

Volumn 330, Issue 7488, 2005, Pages 373-374

  Cipriani, Andrea ^a   Barbui, Corrado ^a   Geddes, John R ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; CHILD; CHILD PSYCHIATRY; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RISK BENEFIT ANALYSIS; SUICIDE; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; NOTE; STATISTICS;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; SUICIDE;

EID: 13844320384     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.330.7488.373     Document Type: Editorial

References (12)

1. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386-92.
2. Davies S, Naik PC, Lee AS. Depression, suicide, and the national service framework. BMJ 2001;322:1501-2.
3. National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care. Clinical Guideline 23. London; NICE, 2004. www.nice.org.uk/pdf/CG023quickrefguide.pdf (accessed 6 Feb 2005).
4. Fergusson D, Doucette S, Glass KG, Shapiro S, Healy D, Hebert P, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 2005;330:396-9.
5. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005;330:385-8.
6. Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, et al. Anti-depressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 2005;330:389-93.
7. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004;23:1351-75.
8. Kahn A, Kahn S, Kolts R, Brown WA, Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports, Am J Psychiatry 2003;160:790-2.
9. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA 2004;292:338-43.
10. Medawar C. The antidepressant web-marketing depression and making medicines work. International Journal of Risk & Safety in Medicine 1997;10:75-126.
11. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lantet 2004;363:1341-3.
12. Ruchkin V, Martin A. SSRIs and the developing brain. Lancet 2005;365:451-3.